e-learning
resources
Copenhagen 2005
Monday 19.09.2005
COPD: clinical physiology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Vascular endothelial growth factor in sleep apnea syndrome and chronic obstructive pulmonary disease
K. Tatsumi, Y. Kasahara, K. Kurosu, N. Tanabe, Y. Takiguchi, T. Kuriyama (Chiba, Japan)
Source:
Annual Congress 2005 - COPD: clinical physiology
Session:
COPD: clinical physiology
Session type:
Thematic Poster Session
Number:
2347
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Tatsumi, Y. Kasahara, K. Kurosu, N. Tanabe, Y. Takiguchi, T. Kuriyama (Chiba, Japan). Vascular endothelial growth factor in sleep apnea syndrome and chronic obstructive pulmonary disease. Eur Respir J 2005; 26: Suppl. 49, 2347
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Imaging of complicated pneumonia: what is new?
The physiology of breathlessness
Related content which might interest you:
Is obstructive sleep apnea syndrome a risk factor for pulmonary thromboemboli?
Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects II
Year: 2011
Association of vascular endothelial dysfunction with disease severity in obstructive sleep apnoea
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008
Plasma vascular endothelial growth factor levels in patients with obstructive sleep apnea hypopnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 564s
Year: 2004
The vascular micromilieu in obstructive sleep apnoea
Source: Eur Respir J 2005; 25: 780-782
Year: 2005
Obstructive pulmonary disorder is a potential risk factor of cardiovascular diseases in obstructive sleep apnea
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008
Circulating microparticles and endothelial dysfunction in obstructive sleep apnea syndrome
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008
The impact of obstructive sleep apnoea syndrome on endothelial function in patients with moderate and severe hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 39s
Year: 2005
Endothelial function in obstructive sleep apnea syndrome
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011
Endothelial dysfunction in patients with obstructive sleep apnea independent of metabolic syndrome
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008
Influence of micropaticles harvested from patients affected by obstructive sleep apnea syndrome on endothelial function and vascular reactivity
Source: Annual Congress 2009 - Pathogenesis of sleep-disordered breathing
Year: 2009
Retinal vascular tortuosity in patients with obstructive sleep apnea-chronic obstructive pulmonary disease overlap syndrome
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018
Vascular reactivity in patients with mild-moderate obstructive sleep apnoea
Source: Eur Respir J 2007; 30: Suppl. 51, 332s
Year: 2007
Microparticles and vascular dysfunction in obstructive sleep apnoea
Source: Eur Respir J 2014; 44: 207-216
Year: 2014
Endothelial dysfunction in patients with obstructive sleep apnea
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011
Impact of obstructive sleep apnea and obesity on endothelial dysfunction in children
Source: Virtual Congress 2020 – Respiratory physiology and sleep: from neonates to adults
Year: 2020
Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease
Source: Eur Respir J 2013; 41: 616-620
Year: 2013
Cardiac arrythmias in chronic obstructive pulmonary disease and obstructive sleep apnoea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 645s
Year: 2006
Chronic obstructive pulmonary disease in patients with obstructive sleep apnea
Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep
Year: 2009
Mechanisms and assessment of vascular damage in obstructive sleep apnoea
Source: Annual Congress 2013 –Yernault Lecture “Obstructive sleep apnoea as a model of systemic disease” followed by “Vascular tree and obstructive sleep apnoea”
Year: 2013
Sleep hypoventilation in hypercapnic chronic obstructive pulmonary disease: prevalence and associated factors
Source: Eur Respir J 2003; 21: 977-984
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept